SEC Filing Summary: India Globalization Capital, Inc. (IGC Pharma, Inc.)
Business Context and Reporting Period
This Form 8-K was filed on February 23, 2011, by India Globalization Capital, Inc. (also referenced as IGC Pharma, Inc.). The report serves to disclose the company's results of operations and financial condition for the three months and nine months ended December 31, 2010.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release attached as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing does not explicitly detail material changes versus prior periods within the main text. It directs readers to the attached press release for the announcement of operational results for the periods ended December 31, 2010.
Guidance, Outlook, and Risks
The document contains no specific guidance, outlook, management commentary, or risk factors in the provided text. It notes that the information furnished under Items 2.02, 7.01, and 9.01 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 23, 2011) for actual financial figures regarding the three and nine months ended December 31, 2010.
- Verify the discrepancy between the registrant name "India Globalization Capital, Inc." and the request metadata "IGC Pharma, Inc."
- Confirm whether the press release contains forward-looking statements or updated guidance not present in this 8-K summary.
- Check subsequent filings to see if the information in this press release was later incorporated by reference.